Literature DB >> 17377791

Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer.

Elham Fakhrejahani1, Akiko Miyamoto, Nobuhiko Tanigawa.   

Abstract

PURPOSE: It has been suggested that the gene expression levels of thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) help in the prediction of the response to 5-fluorouracil (5-FU) in vivo and in vitro in gastric cancers.
METHODS: In this study, intratumoral TS and DPD gene expressions were evaluated with real time reverse transcriptional polymerase chain reaction technique to determine the correlation between the expression of these two genes and in vitro sensitivity to 5-FU, assessed by the histoculture drug response assay on 87 patients with gastric adenocarcinoma.
RESULTS: The sensitivity to 5-FU did not show any difference in clinicopathological groups. DPD gene level was higher in undifferentiated (n = 39) than differentiated (n = 48) tumors (P = 0.043). In differentiated tumors, TS gene expression levels were higher in the tumors with relative resistance to 5-FU, while in undifferentiated cases, DPD mRNA levels were higher in tumors that showed resistance to 5-FU in vitro (P = 0.043 and 0.007, respectively). DPD also had significant predictive value for 5-FU sensitivity in undifferentiated cases [R(S) = -0.401, P = 0.011]. TS and DPD gene expression levels were more highly correlated in undifferentiated compared to differentiated cases [R(S) = 0.515 and 0.359, respectively].
CONCLUSIONS: Different gene expression might be responsible for 5-FU sensitivity in gastric cancers of different histologic origin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17377791     DOI: 10.1007/s00280-007-0448-1

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  6 in total

1.  Combination of histoculture drug response assay and qPCR as an effective method to screen biomarkers for personalized chemotherapy in esophageal cancer.

Authors:  Bin Wei; Jiru Wang; Xiaohui Zhang; Zhaoye Qian; Jingjing Wu; Yuan Sun; Qin Han; Li Wan; Jing Zhu; Yong Gao; Xiaofei Chen
Journal:  Oncol Lett       Date:  2017-09-26       Impact factor: 2.967

2.  Polymorphism of thymidylate synthase gene associated with its protein expression in human colon cancer.

Authors:  Kai-Huan Yu; Wei-Xing Wang; You-Ming Ding; Hui Li; Ze-Sheng Wang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

3.  Evaluation of novel histone deacetylase inhibitors as therapeutic agents for colorectal adenocarcinomas compared to established regimens with the histoculture drug response assay.

Authors:  Jin C Kim; Dae D Kim; Yoo M Lee; Tae W Kim; Dong H Cho; Moon B Kim; Seong G Ro; Seon Y Kim; Yong S Kim; Jung S Lee
Journal:  Int J Colorectal Dis       Date:  2008-10-01       Impact factor: 2.571

Review 4.  The Impact of the Expression Level of Intratumoral Dihydropyrimidine Dehydrogenase on Chemotherapy Sensitivity and Survival of Patients in Gastric Cancer: A Meta-Analysis.

Authors:  Cong Zhang; Hongpeng Liu; Bin Ma; Yongxi Song; Peng Gao; Yingying Xu; Dehao Yu; Zhenning Wang
Journal:  Dis Markers       Date:  2017-01-31       Impact factor: 3.434

5.  Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase.

Authors:  Ayako Nakamura; Go Nakajima; Ryuji Okuyama; Hidekazu Kuramochi; Yurin Kondoh; Toshinori Kanemura; Teiji Takechi; Masakazu Yamamoto; Kazuhiko Hayashi
Journal:  Gastric Cancer       Date:  2013-03-15       Impact factor: 7.370

6.  Corosolic acid reduces 5‑FU chemoresistance in human gastric cancer cells by activating AMPK.

Authors:  Jun Beom Park; Jin Sun Lee; Myung Sun Lee; Eun Young Cha; Soyeon Kim; Ji Young Sul
Journal:  Mol Med Rep       Date:  2018-07-03       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.